id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-266175-4jyltfus	Brendish, Nathan J	Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study	2020-10-08		.txt	text/plain	5468	243	47	METHODS: We did a prospective, interventional, non-randomised, controlled study of molecular point-of-care testing in patients aged 18 years or older presenting with suspected COVID-19 to the emergency department or other acute areas of Southampton General Hospital during the first wave of the pandemic in the UK. [5] [6] [7] [8] The aim of this trial was to assess the clinical impact and real-world diagnostic accuracy of point-of-care testing using the QIAstat-Dx Respiratory SARS-CoV-2 Panel (Qiagen, Hilden, Germany) in adults presenting with suspected COVID-19 during the first wave of the pandemic in the UK. This prospective, non-randomised, controlled trial of routine point-of-care testing for COVID-19 in hospital shows the feasibility of point-of-care testing with the QIAstat-Dx Respiratory SARS-CoV-2 Panel, and shows clinical benefits across a range of outcome measures including time to results, infection control measures, and recruitment into clinical trials compared with a control group tested by centralised laboratory PCR.	./cache/cord-266175-4jyltfus.txt	./txt/cord-266175-4jyltfus.txt